A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells

Inhibition of the mitogenic insulin-like growth factor receptor 1 (IGF-1R) signaling axis is a compelling treatment strategy for prostate cancer. Combining the IGF-1R inhibitor ganitumab (formerly AMG 479) with standard of care androgen-deprivation therapy greatly delays prostate cancer recurrence i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahrenholtz, Cale D, Greene, Ann M, Beltran, Pedro J, Burnstein, Kerry L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253414/
https://www.ncbi.nlm.nih.gov/pubmed/25344862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253414/
https://www.ncbi.nlm.nih.gov/pubmed/25344862

Ejemplares similares